Abnormal NF-κB Function Characterizes Human Type 1 Diabetes Dendritic Cells and Monocytes1

Dendritic cell (DC) differentiation is abnormal in type 1 diabetes mellitus (T1DM). However, the nature of the relationship between this abnormality and disease pathogenesis is unknown. We studied the LPS response in monocytes and monocyte-derived DCs isolated from T1DM patients and from non-T1DM controls. In T1DM patients, late LPS-mediated nuclear DNA binding by RelA, p50, c-Rel, and RelB was impaired as compared with type 2 DM, rheumatoid arthritis, and healthy subjects, associated with impaired DC CD40 and MHC class I induction but normal cytokine production. In TIDM monocytes, RelA and RelB were constitutively activated, and the src homology 2 domain-containing protein tyrosine phosphatase (SHP-1), a negative regulator of NF-κB, was overexpressed. Addition of sodium stibogluconate, a SHP-1 inhibitor, to DCs differentiating from monocyte precursors restored their capacity to respond to LPS in ∼60% of patients. The monocyte and DC NF-κB response to LPS is thus a novel phenotypic and likely pathogenetic marker for human T1DM. SHP-1 is at least one NF-κB regulatory mechanism which might be induced as a result of abnormal inflammatory signaling responses in T1DM monocytes.

[1]  Ranjeny Thomas,et al.  Dendritic cells and the pathogenesis of rheumatoid arthritis , 1999, Journal of leukocyte biology.

[2]  S. Ghosh,et al.  RelB Forms Transcriptionally Inactive Complexes with RelA/p65* , 2003, Journal of Biological Chemistry.

[3]  S. Maeda,et al.  Dependence of Self-Tolerance on TRAF6-Directed Development of Thymic Stroma , 2005, Science.

[4]  M. Andrassy,et al.  Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.

[5]  Michel Goldman,et al.  An Alternative Pathway of NF-κB Activation Results in Maturation and T Cell Priming Activity of Dendritic Cells Overexpressing a Mutated IκBα1 , 2007, The Journal of Immunology.

[6]  G. Bren,et al.  Transcription of the RelB gene is regulated by NF-κB , 2001, Oncogene.

[7]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[8]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[9]  U. Lorenz,et al.  The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. , 1999, International immunology.

[10]  Ranjeny Thomas.  The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation , 2005, Arthritis research & therapy.

[11]  A. Ullrich,et al.  The Ability of Protein Tyrosine Phosphatase SHP-1 to Suppress NFκB Can Be Inhibited by Dominant Negative Mutant of SIRPα , 2004 .

[12]  J. Epstein,et al.  Novel and Detrimental Effects of Lipopolysaccharide on In Vitro Generation of Immature Dendritic Cells: Involvement of Mitogen-Activated Protein Kinase p38 1 , 2003, The Journal of Immunology.

[13]  A. Khaled,et al.  Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B. , 1998, Cellular immunology.

[14]  Y. Xia,et al.  RelB regulation of chemokine expression modulates local inflammation. , 1997, The American journal of pathology.

[15]  Bhagirath Singh,et al.  Characterization of Dendritic Cells in Humans with Type 1 Diabetes , 2003, Annals of the New York Academy of Sciences.

[16]  Jorma Ilonen,et al.  Environmental factors in the etiology of type 1 diabetes. , 2002, American journal of medical genetics.

[17]  M. Eibl,et al.  Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. , 2002, Clinical immunology.

[18]  A. Poole,et al.  A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. , 2005, Cellular signalling.

[19]  T Pawson,et al.  Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Vig,et al.  Combined Deficiency of p50 and cRel in CD4+ T Cells Reveals an Essential Requirement for Nuclear Factor κB in Regulating Mature T Cell Survival and In Vivo Function , 2003, The Journal of experimental medicine.

[21]  V. Kindler,et al.  A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers , 2001, The Journal of Immunology.

[22]  Hana Kim,et al.  A Fourth IκB Protein within the NF-κB Signaling Module , 2007, Cell.

[23]  R. Thomas,et al.  RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Ranjeny Thomas,et al.  Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. , 2003, Immunity.

[25]  F. Weih,et al.  Multifocal defects in immune responses in RelB-deficient mice. , 1997, Journal of immunology.

[26]  K. Siminovitch,et al.  Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene , 1993, Nature Genetics.

[27]  Bernhard Hemmer,et al.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways , 2003, Nature Immunology.

[28]  Ye Zheng,et al.  Dendritic Cell Development and Survival Require Distinct NF-κB Subunits , 2002 .

[29]  P. Pozzilli,et al.  Low Levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in Patients with Newly Diagnosed Type 1 Diabetes , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  T. Hayashi,et al.  NOD mice are defective in proteasome production and activation of NF-kappaB. , 1999, Molecular and cellular biology.

[31]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[32]  W. Wheat,et al.  Increased NF‐κB activity in B cells and bone marrow‐derived dendritic cells from NOD mice , 2004 .

[33]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[34]  Angus Thompson,et al.  NF-κB as a therapeutic target in autoimmune disease , 2007, Expert opinion on therapeutic targets.

[35]  A. Hoffmann,et al.  Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Waldmann,et al.  The Role of Sp1 and NF-κB in Regulating CD40 Gene Expression* , 2002, The Journal of Biological Chemistry.

[37]  S. Saccani,et al.  Modulation of NF-κB Activity by Exchange of Dimers , 2003 .

[38]  T. Yi,et al.  Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1 , 2001, The Journal of Immunology.

[39]  P. Massa,et al.  Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  K. Siminovitch,et al.  The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis , 2006, Nature Medicine.

[41]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[42]  P. Romeo,et al.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  B. Mordmüller,et al.  Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism , 2003, EMBO reports.

[44]  Takuma Hayashi,et al.  NOD Mice Are Defective in Proteasome Production and Activation of NF-κB , 1999, Molecular and Cellular Biology.

[45]  J. Norris.  Can the sunshine vitamin shed light on type 1 diabetes? , 2001, The Lancet.

[46]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[47]  Zhijian J. Chen.  Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[48]  L. Harrison,et al.  Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. , 1998, Journal of immunology.

[49]  I. Flesch,et al.  Decreased blood dendritic cell counts in type 1 diabetic children. , 2007, Clinical immunology.

[50]  H. Drexhage,et al.  Defective maturation and function of antigen-presenting cells in type 1 diabetes , 1995, The Lancet.

[51]  A. Hoffmann,et al.  Circuitry of nuclear factor κB signaling , 2006 .

[52]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[53]  G. Thomas,et al.  Nuclear localization of RelB is associated with effective antigen-presenting cell function. , 1997, Journal of immunology.

[54]  D. Becker,et al.  Persistent T cell anergy in human type 1 diabetes. , 1999, Journal of immunology.

[55]  H. Drexhage,et al.  Immunohistochemical Characterization of Monocytes-Macrophages and Dendritic Cells Involved in the Initiation of the Insulitis and β-Cell Destruction in NOD Mice , 1994, Diabetes.

[56]  Ye Zheng,et al.  Dendritic cell development and survival require distinct NF-kappaB subunits. , 2002, Immunity.

[57]  M. Peakman,et al.  Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. , 2005, Diabetes.

[58]  Ranjeny Thomas,et al.  CD40 and dendritic cell function. , 2003, Critical reviews in immunology.

[59]  H. Kikutani,et al.  Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development1 , 2001, The Journal of Immunology.

[60]  M. Welham,et al.  Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis. , 2005, Blood.

[61]  Vincent Bours,et al.  Regulation of major histocompatibility complex class I expression by NF-κB-related proteins in breast cancer cells , 1998, Oncogene.

[62]  J. Ludvigsson,et al.  Poor In Vitro Maturation and Pro‐Inflammatory Cytokine Response of Dendritic Cells in Children at Genetic Risk of Type 1 Diabetes , 2004, Scandinavian journal of immunology.

[63]  Mark Peakman,et al.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.

[64]  Li Wu,et al.  Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes , 2006, Nature Immunology.

[65]  I. Frazer,et al.  Nuclear RelB+ cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions , 2002, Immunology and cell biology.

[66]  R. Tisch,et al.  Dendritic Cells from Nonobese Diabetic Mice Exhibit a Defect in NF-κB Regulation Due to a Hyperactive IκB Kinase1 , 2001, The Journal of Immunology.

[67]  H. Strobl,et al.  RelB regulates human dendritic cell subset development by promoting monocyte intermediates. , 2004, Blood.

[68]  Michel Goldman,et al.  Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.